Humana Inc.HUMNYSE
LOADING
|||

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
26 analysts·High coverage
42%
Rating Distribution
Strong Buy
00%
Buy
1142%
Hold
1558%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 5% higher.

Bear Case
$234.00
-14%
Consensus
$288.50
+5%
Bull Case
$345.00
+26%
Price Range26 analysts
Low
Consensus
High
$234.00
$345.00
Current Target
Current Price
$273.54
Upside to Target
$14.96

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 7, 2026Wells Fargo
Humana downgraded to Equal Weight from Overweight at Wells Fargo
Target:$290.00
+3.6%from $279.84
Jan 6, 2026Bernstein
Humana price target raised to $344 from $341 at Bernstein
Target:$344.00
+22.4%from $281.03
Dec 18, 2025Morgan Stanley
Humana price target lowered to $262 from $277 at Morgan Stanley
Target:$262.00
+0.7%from $260.28
Dec 5, 2025Jefferies
Humana upgraded to Buy from Hold at Jefferies
Target:$313.00
+23.7%from $253.02
Nov 25, 2025Barclays
Humana price target lowered to $234 from $245 at Barclays
Target:$234.00
+2.1%from $229.20
Nov 10, 2025Truist Financial
Humana price target lowered to $285 from $300 at Truist
Target:$285.00
+17.4%from $242.75
Oct 14, 2025Truist Financial
Humana price target raised to $300 from $280 at Truist
Target:$300.00
+12.4%from $266.92
Oct 14, 2025Goldman Sachs
Humana initiated with a Sell at Goldman Sachs
Target:$235.00
-13.3%from $271.00
Oct 9, 2025Mizuho Securities
Humana price target raised to $345 from $300 at Mizuho
Target:$345.00
+15.8%from $298.04
Oct 7, 2025Wells Fargo
Humana price target raised to $347 from $344 at Wells Fargo
Target:$347.00
+17.5%from $295.20
Oct 3, 2025Mizuho Securities
Humana updates outside of star ratings positive, says Mizuho
Target:$300.00
+16.9%from $256.62
Oct 3, 2025Barclays
Humana price target lowered to $245 from $315 at Barclays
Target:$245.00
-4.5%from $256.62
Sep 4, 2025Barclays
Humana price target raised to $315 from $275 at Barclays
Target:$315.00
+1.0%from $312.00
Sep 4, 2025Barclays
Humana price target raised to $325 from $275 at Barclays
Target:$325.00
+4.2%from $311.98
Jul 31, 2025Barclays
Humana price target raised to $275 from $268 at Barclays
Target:$275.00
+5.2%from $261.47
Jul 18, 2025Wells Fargo
Humana investors assumed low odds of Stars suit success, says Wells Fargo
Target:$348.00
+60.3%from $217.14
Jun 17, 2025Truist Financial
Humana price target lowered to $280 from $305 at Truist
Target:$280.00
+16.0%from $241.45
Jun 12, 2025Barclays
Humana price target lowered to $268 from $273 at Barclays
Target:$268.00
+14.1%from $234.96
Dec 4, 2024Deutsche Bank
Deutsche Bank Reiterates Hold Rating on Humana (HUM)
Target:$248.00
-13.8%from $287.64
Oct 22, 2024Deutsche Bank
Deutsche Bank Reiterates Hold Rating on Humana (HUM)
Target:$250.00
-4.1%from $260.57
Oct 10, 2024Barclays
Humana price target lowered to $250 from $364 at Barclays
Target:$250.00
+1.9%from $245.45
Oct 8, 2024RBC Capital
Humana price target lowered to $265 from $400 at RBC Capital
Target:$265.00
+12.2%from $236.29
Oct 7, 2024Jefferies
Humana downgraded to Hold from Buy at Jefferies
Target:$253.00
+5.4%from $240.03
Oct 3, 2024Piper Sandler
Piper downgrades Humana on 'large miscalculation' of star stability
Target:$274.00
+14.5%from $239.32
Oct 2, 2024Bank of America Securities
Humana downgraded to Underperform from Neutral at BofA
Target:$247.00
+0.2%from $246.49